Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells
出版年份 2011 全文链接
标题
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells
作者
关键词
-
出版物
CLINICAL & EXPERIMENTAL METASTASIS
Volume 28, Issue 5, Pages 479-491
出版商
Springer Nature
发表日期
2011-03-30
DOI
10.1007/s10585-011-9386-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics
- (2009) Bo Dai et al. BJU INTERNATIONAL
- Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer
- (2009) D. S. Welsbie et al. CANCER RESEARCH
- Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels
- (2009) D. Mahalingam et al. CLINICAL CANCER RESEARCH
- α9β1 Integrin in melanoma cells can signal different adhesion states for migration and anchorage
- (2009) Magnus C. Lydolph et al. EXPERIMENTAL CELL RESEARCH
- Reorganization of the integrin α2 subunit controls cell adhesion and cancer cell invasion in prostate cancer
- (2009) Van Slambrouck INTERNATIONAL JOURNAL OF ONCOLOGY
- LKB1 is required for adiponectin-mediated modulation of AMPK–S6K axis and inhibition of migration and invasion of breast cancer cells
- (2009) L Taliaferro-Smith et al. ONCOGENE
- Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells and role of HDACs
- (2008) E Ridolfi et al. BRITISH JOURNAL OF CANCER
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice
- (2008) M. Lakshman et al. CANCER RESEARCH
- Combination Strategy Targeting the Hypoxia Inducible Factor-1 with Mammalian Target of Rapamycin and Histone Deacetylase Inhibitors
- (2008) H. M.W. Verheul et al. CLINICAL CANCER RESEARCH
- Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer
- (2008) Mari Björkman et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro
- (2008) A. Schayowitz et al. MOLECULAR CANCER THERAPEUTICS
- The α-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells
- (2008) M R Russell et al. ONCOGENE
- Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins
- (2008) Tzu-Hsiu Lai et al. PROSTATE
- RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid
- (2008) Todd M. Morgan et al. PROSTATE
- Neuroendocrine transdifferentiation induced by VPA is mediated by PPARγ activation and confers resistance to antiblastic therapy in prostate carcinoma
- (2008) Adriano Angelucci et al. PROSTATE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started